Last reviewed · How we verify

NCT03850990: GCE

Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss

Completed NA Last updated 4 June 2021
What this trial tests

NA trial testing Placebo pill and no placebo pill in Eating Behavior in 31 participants. Completed in 30 May 2020.

Timeline
25 September 2019
Primary endpoint
30 May 2020
30 May 2020

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment31
Start date25 September 2019
Primary completion30 May 2020
Estimated completion30 May 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 60, any sex, with Eating Behavior or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will assess the effect of attending to stomach-cues of hunger and fullness on body weight and any additional benefit provided by open-label placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eating Behavior

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03850990.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing